Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/dmrr.3330 http://scihub22266oqcxt.onion/10.1002/dmrr.3330 32336007!7267128!32336007     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetes+Metab+Res+Rev 2020 ; 36 (8): e3330 Nephropedia Template TP {{tp|p=32336007|t=2020. DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19?|pdf=|usr=}}{{32336007}} gab.com Text DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19 JO: Diabetes Metab Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=32336007 #FOAvip Dipeptidyl peptidase 4 (DPP4), also known as cluster of differentiation 26 (CD26), is a serine exopeptidase expressed ubiquitously in several tissues, including but not limited to lung, kidney, liver, gut, and immune cells. The question has been raised on whether DPP4 modulation or inhibition may prevent infection and/or progression of the COVID-19. A docked complex model of the SARS-CoV-2 spike glycoprotein and DPP4 has been proposed, showing a large interface between the proteins and proposing close similarity with other coronaviruses using DPP4 as functional receptor. In absence of experimental validation, these data should be interpreted with caution. Nevertheless, this observation may rise the question on whether DPP4 is directly involved in SARS-CoV-2 cell adhesion/virulence, and whether DPP4 inhibition might be a therapeutic strategy for preventing infection. Although a direct involvement of DPP4 in SARS-CoV-2 infection needs to be clarified, there is also evidence suggesting that DPP4 inhibitors modulate inflammation and exert anti-fibrotic activity. These properties may be of potential use for halting progression to the hyperinflammatory state associated with severe COVID-19. Taken together these findings may suggest a potential role for DPP4 inhibition or modulation in one or more steps of COVID-19 immunopathogenesis. Twit Text FOAVip DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19 ????Diabetes Metab Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=32336007 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32336007 #FOAvip English Wikipedia <ref>{{Cite pmid|32336007}}</ref> DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of COVID-19? #MMPMID32336007 Strollo R; Pozzilli P Diabetes Metab Res Rev 2020[Nov]; 36 (8): e3330 PMID32336007show ga Dipeptidyl peptidase 4 (DPP4), also known as cluster of differentiation 26 (CD26), is a serine exopeptidase expressed ubiquitously in several tissues, including but not limited to lung, kidney, liver, gut, and immune cells. The question has been raised on whether DPP4 modulation or inhibition may prevent infection and/or progression of the COVID-19. A docked complex model of the SARS-CoV-2 spike glycoprotein and DPP4 has been proposed, showing a large interface between the proteins and proposing close similarity with other coronaviruses using DPP4 as functional receptor. In absence of experimental validation, these data should be interpreted with caution. Nevertheless, this observation may rise the question on whether DPP4 is directly involved in SARS-CoV-2 cell adhesion/virulence, and whether DPP4 inhibition might be a therapeutic strategy for preventing infection. Although a direct involvement of DPP4 in SARS-CoV-2 infection needs to be clarified, there is also evidence suggesting that DPP4 inhibitors modulate inflammation and exert anti-fibrotic activity. These properties may be of potential use for halting progression to the hyperinflammatory state associated with severe COVID-19. Taken together these findings may suggest a potential role for DPP4 inhibition or modulation in one or more steps of COVID-19 immunopathogenesis. |Betacoronavirus/*drug effects/isolation & purification[MESH] |COVID-19[MESH] |Coronavirus Infections/*prevention & control/transmission/virology[MESH] |Dipeptidyl-Peptidase IV Inhibitors/*therapeutic use[MESH] |Disease Progression[MESH] |Humans[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/*prevention & control/transmission/virology[MESH]DPP4 inhibition: Preventing SARS-CoV-2 infection and/or progression of(epmc).pdf DeepDyve Pubget Overpricing